ストックスクリーナーアプリを入手
1.78
4.71%
0.08
アフターアワーズ：
1.80
0.02
+1.12%
前日終値:
$1.70
開ける：
$1.67
24時間の取引高:
55,197
Relative Volume:
0.39
時価総額：
$3.87M
収益：
$10.48M
当期純損益:
$-37.74M
株価収益率:
-0.11
EPS:
-16.1846
ネットキャッシュフロー:
$-29.03M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-16.43%
6か月 パフォーマンス:
-71.15%
1年 パフォーマンス:
-93.15%
1日の値動き範囲:
$1.655
$1.82
1週間の範囲:
$1.59
$1.9187
52週間の値動き範囲:
$1.5701
$33.25
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
JAGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.78 | 6.30M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
What high frequency data says about Jaguar Health Inc.July 2025 Levels & Precise Buy Zone Identification - newser.com
Short interest data insights for Jaguar Health Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Jaguar Animal Health Secures $10.8M Note Agreement - TipRanks
Jaguar Health Inc. stock trendline breakdownJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Jaguar Health enters $10.8 million secured note agreement with Streeterville Capital - Investing.com
Will Jaguar Health Inc. (1JA0) stock profit from fiscal stimulusJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - York Dispatch
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Lexington Herald Leader
Jaguar Health (NASDAQ: JAGX) to host webcast on Q3 results at 8:30 a.m. ET - Stock Titan
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Daily Commercial
Is Jaguar Health Inc. (1JA0) stock dividend growth reliable2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Has Jaguar Health Inc. formed a bullish divergenceDividend Hike & Intraday High Probability Alerts - newser.com
How dovish Fed policy supports Jaguar Health Inc. (1JA0) stockJuly 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
Is Jaguar Health Inc. showing signs of accumulationMarket Risk Report & Low Volatility Stock Recommendations - newser.com
Jaguar Health (JAGX) Reports Promising Trial Results for Crofelemer in Pediatric Patients - GuruFocus
Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting - Yahoo Finance
Live market analysis of Jaguar Health Inc.Portfolio Update Report & Expert Curated Trade Ideas - newser.com
Can you recover from losses in Jaguar Health Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Jaguar Health Inc Stock Analysis and ForecastMarket Profile Overview & High Return Investment Growth - earlytimes.in
REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutri - The Florida Times-Union
[DEF 14A] Jaguar Health, Inc. Definitive Proxy Statement - Stock Titan
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Newport Daily News
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.07%
大文字化:
|
ボリューム (24 時間):